PT1056458E - Tratamento de dor cronica - Google Patents
Tratamento de dor cronicaInfo
- Publication number
- PT1056458E PT1056458E PT99936030T PT99936030T PT1056458E PT 1056458 E PT1056458 E PT 1056458E PT 99936030 T PT99936030 T PT 99936030T PT 99936030 T PT99936030 T PT 99936030T PT 1056458 E PT1056458 E PT 1056458E
- Authority
- PT
- Portugal
- Prior art keywords
- chronic pain
- pain treatment
- chronic
- metanicotine
- suffering
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7579498P | 1998-02-24 | 1998-02-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1056458E true PT1056458E (pt) | 2005-08-31 |
Family
ID=22128028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99936030T PT1056458E (pt) | 1998-02-24 | 1999-02-24 | Tratamento de dor cronica |
Country Status (13)
Country | Link |
---|---|
US (1) | US6248744B1 (pt) |
EP (1) | EP1056458B1 (pt) |
JP (1) | JP2002504512A (pt) |
KR (2) | KR20060085258A (pt) |
AT (1) | ATE293972T1 (pt) |
AU (1) | AU3308099A (pt) |
BR (1) | BR9908190A (pt) |
CA (1) | CA2321991A1 (pt) |
DE (1) | DE69924979T2 (pt) |
ES (1) | ES2242405T3 (pt) |
MX (1) | MXPA00008273A (pt) |
PT (1) | PT1056458E (pt) |
WO (1) | WO1999043322A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6248788B1 (en) | 1996-11-06 | 2001-06-19 | The Regents Of The University Of California | Therapeutic method with capsaicin and capasicin analogs |
US6239180B1 (en) | 1995-11-08 | 2001-05-29 | The Regents Of The University Of California | Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
US6448276B1 (en) * | 2000-05-17 | 2002-09-10 | Inspire Pharmaceuticals, Inc. | Method for treating vaginal dryness with nicotinic acetylcholine receptor agonists |
WO2003022261A1 (en) | 2001-09-13 | 2003-03-20 | Miller Kenneth E | Method of alleviating pain |
CA2392486A1 (en) | 2002-07-05 | 2002-12-08 | Duchesnay Inc. | Pharmaceutical dosage form bearing pregnancy-friendly indicia |
EP1587506B1 (en) * | 2002-12-18 | 2008-07-23 | Algorx | Administration of capsaicinoids |
US20050019436A1 (en) * | 2002-12-18 | 2005-01-27 | Algorx | Injectable capsaicin |
BRPI0409748A (pt) * | 2003-04-08 | 2006-10-24 | Algorx Pharmaceuticals Inc | preparação e purificação de capsaicin sintetico |
WO2007055928A1 (en) * | 2005-11-03 | 2007-05-18 | Targacept, Inc. | 5-membered ring metanicotine analogs |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5212188A (en) * | 1992-03-02 | 1993-05-18 | R. J. Reynolds Tabacco Company | Method for treatment of neurodegenerative diseases |
US5604231A (en) * | 1995-01-06 | 1997-02-18 | Smith; Carr J. | Pharmaceutical compositions for prevention and treatment of ulcerative colitis |
US5663357A (en) * | 1995-11-22 | 1997-09-02 | Allergan | Substituted heteroarylamides having retinoid-like biological activity |
US5616716A (en) * | 1996-01-06 | 1997-04-01 | Dull; Gary M. | (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds |
US5861423A (en) * | 1997-02-21 | 1999-01-19 | Caldwell; William Scott | Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds |
US5811442A (en) * | 1997-02-21 | 1998-09-22 | Bencherif; Merouane | Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow |
-
1999
- 1999-02-24 PT PT99936030T patent/PT1056458E/pt unknown
- 1999-02-24 JP JP2000533119A patent/JP2002504512A/ja active Pending
- 1999-02-24 MX MXPA00008273A patent/MXPA00008273A/es not_active IP Right Cessation
- 1999-02-24 KR KR1020067013505A patent/KR20060085258A/ko not_active Application Discontinuation
- 1999-02-24 CA CA002321991A patent/CA2321991A1/en not_active Abandoned
- 1999-02-24 AT AT99936030T patent/ATE293972T1/de not_active IP Right Cessation
- 1999-02-24 AU AU33080/99A patent/AU3308099A/en not_active Abandoned
- 1999-02-24 KR KR1020007009370A patent/KR100703640B1/ko not_active IP Right Cessation
- 1999-02-24 ES ES99936030T patent/ES2242405T3/es not_active Expired - Lifetime
- 1999-02-24 BR BR9908190-3A patent/BR9908190A/pt not_active Application Discontinuation
- 1999-02-24 EP EP99936030A patent/EP1056458B1/en not_active Expired - Lifetime
- 1999-02-24 WO PCT/US1999/003896 patent/WO1999043322A1/en not_active Application Discontinuation
- 1999-02-24 DE DE69924979T patent/DE69924979T2/de not_active Expired - Lifetime
- 1999-02-24 US US09/622,675 patent/US6248744B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2242405T3 (es) | 2005-11-01 |
AU3308099A (en) | 1999-09-15 |
DE69924979T2 (de) | 2006-01-19 |
WO1999043322A1 (en) | 1999-09-02 |
ATE293972T1 (de) | 2005-05-15 |
BR9908190A (pt) | 2000-10-24 |
EP1056458B1 (en) | 2005-04-27 |
KR20060085258A (ko) | 2006-07-26 |
US6248744B1 (en) | 2001-06-19 |
KR100703640B1 (ko) | 2007-04-05 |
JP2002504512A (ja) | 2002-02-12 |
MXPA00008273A (es) | 2002-04-24 |
KR20010096465A (ko) | 2001-11-07 |
DE69924979D1 (de) | 2005-06-02 |
CA2321991A1 (en) | 1999-09-02 |
EP1056458A1 (en) | 2000-12-06 |
EP1056458A4 (en) | 2001-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20101190L (no) | Anvendelse av buprenorfin i fremstillingen av et medikament | |
ATE303162T1 (de) | Natrium kanalblocker zusammensetzungen und deren verwendung | |
DE69921156D1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
ATE207356T1 (de) | Verwendung von tiagabin zur behandlung von schlafstörungen | |
DK0723444T3 (da) | Levobupivacain, som er egnet til behandling af kronisk smerte | |
DE69929464D1 (de) | Zyklische polyamine zur behandlung der thrombozytopenie | |
DE69814394D1 (de) | Verwendung von levobupivacain | |
HK1051490A1 (en) | Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs. | |
ATE214272T1 (de) | Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz | |
PT1056458E (pt) | Tratamento de dor cronica | |
ATE296098T1 (de) | Verwendung von topiramat zur behandlung und diagnostizierung von atemstörungen während des schlafens und mittel zur durchführung der behandlung und diagnose | |
EA199800864A1 (ru) | Способ лечения при боли, вызванной мигренью | |
ATE302011T1 (de) | PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN | |
ATE261724T1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
MY124071A (en) | Treatment of viral disease in swine | |
NO984189L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
ATE545423T1 (de) | Mittel zur behandlung von lungenkrebs | |
ATE291434T1 (de) | Verwendung von angiotensin zur behandlung von krebsmetastasierung | |
AUPP379698A0 (en) | Using ngali nut oil to treat/relieve the pain of arthritis and other similar conditions | |
TR199801801T2 (xx) | Madde k�t�ye kullan�m�n�n tedavisi. | |
DE60024408D1 (de) | Verwendung von trizyklischen antidepressiva zur behandlung von kopfschmerzen | |
NO20024545D0 (no) | Fremgangsmåte for behandling av kongestiv hjertefeil | |
ATE271867T1 (de) | Behandlung der harninkontinenz und zusammenstellung dafür | |
NO984198L (no) | FremgangsmÕte for behandling av aggresjon | |
ATE319443T1 (de) | Prävention oder behandlung von brust-, prostata- und/oder gebärmutterhalskrebs mit n,n- dimethylglycin |